Logo

Bronchitis Cochrane Pediatric Emergency Medicine Reviews

Browse Cochrane Pediatric Emergency Medicine Reviews
Browse Cochrane Pediatric Emergency Medicine Reviews

Cochrane Systematic Review: Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children

Cochrane Systematic Review: Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children

Visit

Mulholland S, Gavranich JB, Gillies MB, Chang AB

Mulholland S, Gavranich JB, Gillies MB, Chang AB

OBJECTIVES: To determine whether antibiotics are effective in the treatment of childhood LRTI secondary to M. pneumoniae infections acquired in the community.

OBJECTIVES: To determine whether antibiotics are effective in the treatment of childhood LRTI secondary to M. pneumoniae infections acquired in the community.

Cochrane Systematic Review: Azithromycin for respiratory tract infections

Cochrane Systematic Review: Azithromycin for respiratory tract infections

Visit

Panpanich R, Lerttrakarnnon P, Laopaiboon M

Panpanich R, Lerttrakarnnon P, Laopaiboon M

OBJECTIVES: To compare the effectiveness of azithromycin to amoxycillin or amoxycillin/clavulanic acid (amoxyclav) in the treatment of LRTI, in terms of clinical failure, incidence of adverse events and microbial eradication.

OBJECTIVES: To compare the effectiveness of azithromycin to amoxycillin or amoxycillin/clavulanic acid (amoxyclav) in the treatment of LRTI, in terms of clinical failure, incidence of adverse events and microbial eradication.

Cochrane Systematic Review: Beta2-agonists for bronchitis

Cochrane Systematic Review: Beta2-agonists for bronchitis

Visit

Becker LA, Hom J, Villasis-Keever M, van der Wouden JC

Becker LA, Hom J, Villasis-Keever M, van der Wouden JC

OBJECTIVES: To determine whether beta2-agonists improve bronchitis symptoms in patients with no underlying pulmonary disease.

OBJECTIVES: To determine whether beta2-agonists improve bronchitis symptoms in patients with no underlying pulmonary disease.

Cochrane Systematic Review: Chinese medicinal herbs for bronchitis

Cochrane Systematic Review: Chinese medicinal herbs for bronchitis

Visit

Jiang L, Li K, Wu T

Jiang L, Li K, Wu T

OBJECTIVES: This review aimed to summarise the existing evidence on the comparative effectiveness and safety of Chinese medicinal herbs for treating uncomplicated bronchitis.

OBJECTIVES: This review aimed to summarise the existing evidence on the comparative effectiveness and safety of Chinese medicinal herbs for treating uncomplicated bronchitis.

Cochrane Systematic Review: Pelargonium sidoides extract for treating acute respiratory tract infections

Cochrane Systematic Review: Pelargonium sidoides extract for treating acute respiratory tract infections

Visit

Timmer A, Gnther J, Motschall E, Rcker G, Antes G, Kern WV.

Timmer A, Gnther J, Motschall E, Rcker G, Antes G, Kern WV.

Objectives: To assess the efficacy and safety of P. sidoides for the treatment of ARIs in children and adults.

Objectives: To assess the efficacy and safety of P. sidoides for the treatment of ARIs in children and adults.

Cochrane Systematic Review: Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children

Cochrane Systematic Review: Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children

Visit

Mulholland S, Gavranich JB, Gillies MB, Chang AB

Mulholland S, Gavranich JB, Gillies MB, Chang AB

OBJECTIVES: To determine whether antibiotics are effective in the treatment of childhood LRTI secondary to M. pneumoniae infections acquired in the community.

OBJECTIVES: To determine whether antibiotics are effective in the treatment of childhood LRTI secondary to M. pneumoniae infections acquired in the community.

Cochrane Systematic Review: Azithromycin for respiratory tract infections

Cochrane Systematic Review: Azithromycin for respiratory tract infections

Visit

Panpanich R, Lerttrakarnnon P, Laopaiboon M

Panpanich R, Lerttrakarnnon P, Laopaiboon M

OBJECTIVES: To compare the effectiveness of azithromycin to amoxycillin or amoxycillin/clavulanic acid (amoxyclav) in the treatment of LRTI, in terms of clinical failure, incidence of adverse events and microbial eradication.

OBJECTIVES: To compare the effectiveness of azithromycin to amoxycillin or amoxycillin/clavulanic acid (amoxyclav) in the treatment of LRTI, in terms of clinical failure, incidence of adverse events and microbial eradication.

Cochrane Systematic Review: Beta2-agonists for bronchitis

Cochrane Systematic Review: Beta2-agonists for bronchitis

Visit

Becker LA, Hom J, Villasis-Keever M, van der Wouden JC

Becker LA, Hom J, Villasis-Keever M, van der Wouden JC

OBJECTIVES: To determine whether beta2-agonists improve bronchitis symptoms in patients with no underlying pulmonary disease.

OBJECTIVES: To determine whether beta2-agonists improve bronchitis symptoms in patients with no underlying pulmonary disease.

Cochrane Systematic Review: Chinese medicinal herbs for bronchitis

Cochrane Systematic Review: Chinese medicinal herbs for bronchitis

Visit

Jiang L, Li K, Wu T

Jiang L, Li K, Wu T

OBJECTIVES: This review aimed to summarise the existing evidence on the comparative effectiveness and safety of Chinese medicinal herbs for treating uncomplicated bronchitis.

OBJECTIVES: This review aimed to summarise the existing evidence on the comparative effectiveness and safety of Chinese medicinal herbs for treating uncomplicated bronchitis.

Cochrane Systematic Review: Pelargonium sidoides extract for treating acute respiratory tract infections

Cochrane Systematic Review: Pelargonium sidoides extract for treating acute respiratory tract infections

Visit

Timmer A, Gnther J, Motschall E, Rcker G, Antes G, Kern WV.

Timmer A, Gnther J, Motschall E, Rcker G, Antes G, Kern WV.

Objectives: To assess the efficacy and safety of P. sidoides for the treatment of ARIs in children and adults.

Objectives: To assess the efficacy and safety of P. sidoides for the treatment of ARIs in children and adults.